Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1823 (LINC01823)

Target
LINC01823
Molecular classification
Long non-coding RNA, Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 1823 (LINC01823) is a human gene that produces a long non-coding RNA molecule longer than 200 nucleotides, transcribed from an intergenic genomic region that does not overlap annotated protein-coding genes. LINC01823 is annotated and catalogued in major genomic databases but is as yet functionally uncharacterized. Other lincRNAs function in gene regulation, chromatin remodeling, RNA stabilization, and enhancer-associated activities, often exhibiting tissue specificity, but specific biological activities and disease associations for LINC01823 are presently unknown[1][3].LINC01823 is distinct from protein-coding genes and does not encode a receptor, enzyme, or similar molecular target. It belongs in the class of long intergenic non-coding RNAs, molecules that modulate biological processes, often related to gene regulation but generally not as direct drug targets. Most lincRNAs, including LINC01823, await functional characterization, and structured data regarding its physiology, pathology, or drug interactions are currently lacking[1][3][5].

Other names
LINC01823
02

Biological functions

As a member of the lincRNA class, possible functions include regulation of chromatin structure, gene expression modulation, enhancer-like activities, and possibly participation in transcriptional regulation through sequence-dependent or -independent mechanisms. No specific role is yet assigned for LINC01823 itself.
03

Disease associations

No direct evidence yet links LINC01823 to specific disease roles such as cancer or cardiovascular disease. lincRNAs in general are increasingly studied for associations with diverse conditions, but LINC01823 has not been specifically implicated.

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1823 (LINC01823).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1823 (LINC01823).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call